90 related articles for article (PubMed ID: 15843096)
21. [Depression and frontal dysfunction: risks for the elderly?].
Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
[TBL] [Abstract][Full Text] [Related]
22. Cognitive assessment of a trekking expedition to 5100 m: a comparison of computerized and written testing methods.
Harris GA; Cleland J; Collie A; McCrory P
Wilderness Environ Med; 2009; 20(3):261-8. PubMed ID: 19737042
[TBL] [Abstract][Full Text] [Related]
23. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy.
Lutz MT; Helmstaedter C
Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826
[TBL] [Abstract][Full Text] [Related]
24. Assessment of medication management by community-living elderly persons with two standardized assessment tools: a cross-sectional study.
Hutchison LC; Jones SK; West DS; Wei JY
Am J Geriatr Pharmacother; 2006 Jun; 4(2):144-53. PubMed ID: 16860261
[TBL] [Abstract][Full Text] [Related]
25. Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes.
Brands AM; Kessels RP; Hoogma RP; Henselmans JM; van der Beek Boter JW; Kappelle LJ; de Haan EH; Biessels GJ
Diabetes; 2006 Jun; 55(6):1800-6. PubMed ID: 16731845
[TBL] [Abstract][Full Text] [Related]
26. Long-term cognitive function following chemotherapy in patients with testicular cancer.
Pedersen AD; Rossen P; Mehlsen MY; Pedersen CG; Zachariae R; von der Maase H
J Int Neuropsychol Soc; 2009 Mar; 15(2):296-301. PubMed ID: 19203434
[TBL] [Abstract][Full Text] [Related]
27. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
[TBL] [Abstract][Full Text] [Related]
28. White matter microstructural integrity and cognitive function in a general elderly population.
Vernooij MW; Ikram MA; Vrooman HA; Wielopolski PA; Krestin GP; Hofman A; Niessen WJ; Van der Lugt A; Breteler MM
Arch Gen Psychiatry; 2009 May; 66(5):545-53. PubMed ID: 19414714
[TBL] [Abstract][Full Text] [Related]
29. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.
Schagen SB; Das E; van Dam FS
Psychooncology; 2009 Jun; 18(6):674-8. PubMed ID: 19021129
[TBL] [Abstract][Full Text] [Related]
30. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
Psychooncology; 2009 Aug; 18(8):811-21. PubMed ID: 19085975
[TBL] [Abstract][Full Text] [Related]
31. Cognitive function after chemotherapy in adults with solid tumours.
Vardy J; Tannock I
Crit Rev Oncol Hematol; 2007 Sep; 63(3):183-202. PubMed ID: 17678745
[TBL] [Abstract][Full Text] [Related]
32. The effect of cataract surgery on neuropsychological test performance: a randomized controlled trial.
Anstey KJ; Lord SR; Hennessy M; Mitchell P; Mill K; von Sanden C
J Int Neuropsychol Soc; 2006 Sep; 12(5):632-9. PubMed ID: 16961944
[TBL] [Abstract][Full Text] [Related]
33. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function.
Jansen CE; Miaskowski C; Dodd M; Dowling G; Kramer J
Cancer; 2005 Nov; 104(10):2222-33. PubMed ID: 16206292
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the usability of a brief computerized cognitive screening test in older people for epidemiological studies.
Fredrickson J; Maruff P; Woodward M; Moore L; Fredrickson A; Sach J; Darby D
Neuroepidemiology; 2010; 34(2):65-75. PubMed ID: 20016215
[TBL] [Abstract][Full Text] [Related]
35. Prospective evaluation of pretreatment executive cognitive impairment and depression in patients referred for radiotherapy.
Fuller CD; Schillerstrom JE; Jones WE; Boersma M; Royall DR; Fuss M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):529-33. PubMed ID: 18411001
[TBL] [Abstract][Full Text] [Related]
36. [Use of the Cambridge Neuropsychological Test Automated Battery for the diagnosis of mild cognitive impairment. A pilot study in a Spanish sample].
Facal D; Rodríguez N; Juncos-Rabadán O; Manuel Caamaño J; Sueiro J
Rev Esp Geriatr Gerontol; 2009; 44(2):79-84. PubMed ID: 19285365
[TBL] [Abstract][Full Text] [Related]
37. Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results.
Weis J; Poppelreuter M; Bartsch HH
Psychooncology; 2009 Jul; 18(7):775-82. PubMed ID: 19061196
[TBL] [Abstract][Full Text] [Related]
38. Effects of symptom reduction and psychotropic medication on cognitive impairment in depression.
Frasch K; Bullacher C; Jäger M; Kilian R; Rink M; Wittek R; Becker T; Neumann NU
Psychopathology; 2009; 42(1):59-66. PubMed ID: 19127101
[TBL] [Abstract][Full Text] [Related]
39. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study.
Jenkins VA; Bloomfield DJ; Shilling VM; Edginton TL
BJU Int; 2005 Jul; 96(1):48-53. PubMed ID: 15963119
[TBL] [Abstract][Full Text] [Related]
40. Measuring impairments in memory and executive function in older people using the Revised Cambridge Cognitive Examination.
Kessels RP; Mimpen G; Melis R; Rikkert MG
Am J Geriatr Psychiatry; 2009 Sep; 17(9):793-801. PubMed ID: 19700951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
